![](https://assets.isu.pub/document-structure/230202164140-632c77692f09657c08a923bcd1ef4b62/v1/6c348e8abe4d34ee5d2b15f334f91d52.jpeg?width=720&quality=85%2C50)
1 minute read
Diagnosis of Multiple Myeloma
![](https://assets.isu.pub/document-structure/230202164140-632c77692f09657c08a923bcd1ef4b62/v1/525fe2cb607378f653c8205ac3230c8a.jpeg?width=720&quality=85%2C50)
• Conventional X-rays reveal punched-out lytic lesions, osteoporosis, or fractures in 75% of patients.
• FDG PET/CT appears to be more sensitive (85%) than skeletal survey for the detection of small lytic bone lesions.
• Diagnosis is confirmed with bone marrow demonstrating greater than 10% involvement by malignant plasma cells with either CRAB or SLiM
Malignant Plasma cells seen on biopsy
AND ≥1 “CRAB” feature
C: Calcium elevation (>11 mg/dL)
R: Renal- low kidney function; (serum creatinine >2 mg/dL)
A: Anemia –low red blood count (Hb <10 g/dL)
![](https://assets.isu.pub/document-structure/230202164140-632c77692f09657c08a923bcd1ef4b62/v1/94e1d04933542609fdf4bd963a9c3dd1.jpeg?width=720&quality=85%2C50)
![](https://assets.isu.pub/document-structure/230202164140-632c77692f09657c08a923bcd1ef4b62/v1/759499a1efa597b1eccbc92a526c9da0.jpeg?width=720&quality=85%2C50)
B: Bone disease (≥1 lytic lesions on skeletal radiography, CT, or PET-CT)
OR have >1 SLiM ‘high risk” features:
S: >60% Plasma Cells on Bone Marrow biopsy
Li: Serum light chain ratio >100
M: >1 lytic lesions on MRI (or PET/ CT scan)
![](https://assets.isu.pub/document-structure/230202164140-632c77692f09657c08a923bcd1ef4b62/v1/374e4a14010d6be328ba5a3f42c05db5.jpeg?width=720&quality=85%2C50)